NOVARTIS drug ADAKVEO receives new J-code effective 7/1/2020

Join

My Profile

Login

About Us

Mission
Board of Trustees
Group Purchasing Organization (GPO)

Membership

Benefits
Oncology Practice Membership
Corporate Membership

News & Events

Latest News
Upcoming Events
Annual Conference

Resources

Oncology Resources Websites
Patient Assistance Programs

Corporate Members

Members Only

Bylaws
Membership Directory
Law Newsletter Archive
Reimbursement & Legislative News
Archived Meeting Data

Complete Story

NOVARTIS drug ADAKVEO receives new J-code effective 7/1/2020

Printer-Friendly Version

Join NJSOM

Resources

News & Events

Member Resources

Corporate Members view all sponsors

Takeda Oncology

AmerisourceBergen Oncology Supply

Daiichi Sankyo (DSI)

Bristol Myers Squibb

Gilead Oncology

Boehringer-Ingelheim Pharmacueticals

©2024 New Jersey Society of Oncology Managers
PO Box 95 | Florham Park NJ 07932
tel: 1.800.658.5011 | fax: 973.453.8133 | email: info@njsom.org

Developed by TCS Software